An alternatively spliced KAI1 mRNA is expressed at low levels in human bladder cancers and bladder cancer cell lines and is not associated with invasive behaviour

Oncology Reports

Volumn 18, Issue 6, 2007, Pages 1357-1363

  Jackson, Paul ^a   Rowe, Alexandra ^a   Grimm, Marc Oliver ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Alternative splicing; KAI1; Metastasis suppressor; Urological cancer

Indexed keywords

CD82 ANTIGEN; CD82 PROTEIN, HUMAN; MESSENGER RNA; PRIMER DNA; RNA; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; BLADDER TUMOR; CANCER INVASION; CELL LINE; FOLLOW UP; GENETICS; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ALTERNATIVE SPLICING; BASE SEQUENCE; CELL LINE; CELL LINE, TUMOR; DNA PRIMERS; FOLLOW-UP STUDIES; HUMANS; KANGAI-1 PROTEIN; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; URINARY BLADDER NEOPLASMS;

EID: 38449117129     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.6.1357     Document Type: Article

References (29)

1. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268: 884-886, 1995.
2. Tonoli H and Barrett JC: CD82 metastasis suppressor gene: a potential target for new therapeutics: Trends Mol Med 11: 563-570, 2005. (Pubitemid 41713998)
3. Liu WM and Zhang XA: KAI1/CD82, a tumour metastasis suppressor. Cancer Lett 240: 183-194, 2006.
4. Adachi M, Taki T, Ieki Y, Huang CI, Higashiyama M and Miyake M: Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 56: 1751-1755, 1996. (Pubitemid 26118208)
5. Schindl M, Birner P, Breitenecker G and Oberhuber G: Down-regulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer. Gynecol Oncol 83: 244-248, 2001. (Pubitemid 33033060)
6. Huang CI, Kohno N, Ogawa E, Adachi M, Taki T and Miyake M: Correlation of reduction in MRP/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am J Pathol 153: 973-983, 1998. (Pubitemid 28419050)
7. Su JS, Arima K, Hasegawa M, Franco O, Umeda Y, Yanagawa M, Sugimura Y, et al: Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma. Int J Urol 11: 74-82, 2004. (Pubitemid 38270455)
8. Dong JT, Suzuki H, Pin SS, Bova S, Schalken JA, Isaacs WB, Barrett JC, et al: Down-regulation of the KAI1 metastasis gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res 56: 4387-4390, 1996. (Pubitemid 26330445)
9. Jackson P, Millar D, Kingsley E, Yardley G, Ow K, Clark S and Russell PJ: Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines. Cancer Lett 157: 169-176, 2000. (Pubitemid 30629028)
10. Sekita N, Suzuki H, Ichikawa T, Kito H, Akakura K, Igarashi T, Nakayama T, et al: Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines. Jpn J Cancer Res 92: 947-951, 2001. (Pubitemid 32970435)
11. Marreiros A, Czolij R, Yardley G, Crossley M and Jackson P: Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53. Gene 302: 155-164, 2003. (Pubitemid 36078407)
12. Marreiros A, Dudgeon K, Dao V, Grimm MO, Czolij R, Crossley M and Jackson P: KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells. Oncogene 24: 637-649, 2005. (Pubitemid 40188568)
13. Kim JH, Kim B, Cai L, Choi HJ, Ohgi KA, Tran C, Chen C, et al:Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes. Nature 434: 921-926, 2005. (Pubitemid 40559007)
14. Ow K, Fisher R, Delprado W, Barrett J, Yardley G, Jackson P and Russell PJ: The relationship between KAI1 expression and other markers of bladder cancer progression. J Pathol 191: 39-47, 2000. (Pubitemid 30235647)
15. Burchert A, Notter M, Menssen HD, Schwartz S, Knauf W, Neubauer A and Ekhart T: CD82 (KAI1), a member of the tetraspan family, is expressed on early haemopoietic progenitor cells and up-regulated in distinct human leukaemias. Br J Haematol 10: 494-504, 1999.
16. Yang JL, Jackson P, Yu Y, Yoshie O, Ham JM, Russell PJ and Crowe PJ: Invasion and metastasis correlate with down-regulation of KAI1 expression in human colon cancer cell lines. GI Cancer 3: 313-322, 2001. (Pubitemid 34059345)
17. Guo X, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Korc M and Buchler MW: KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastasis. Cancer Res 56: 4876-4880, 1996. (Pubitemid 26374422)
18. Bouras T and Frauman AG: Expression of the prostate cancer metastasis suppressor KAI1 in primary prostate cancers: a biphasic relationship with tumour grade. J Pathol 188: 382-388, 1999. (Pubitemid 29327436)
19. Guo XZ, Friess H, Maurer C, Berberat P, Tang WH, Zimmermann A, Naef M, et al: KAI1 is unchanged in metastatic and non-metastatic esophogeal and gastric cancers. Cancer Res 58: 753-758, 1998. (Pubitemid 28099488)
20. Lee JH, Seo YW, Park SR, Kim YJ and Kim KK: Expression of a splice variant of KAI1, a tumour metastasis suppressor gene, influences tumour invasion and progression. Cancer Res 63: 7247-7255, 2003. (Pubitemid 37413464)
21. Lee JH, Park SR, Chay KO, Seo YW, Kook H, Ahn KY, Kim YJ, et al: KAI1 COOH-Terminal interacting Tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumour metastasis suppressor and enhances metastasis of cancer. Cancer Res 64: 4235-4243, 2004. (Pubitemid 38802428)
22. Sobin LH and Wittekind C: TNM Classification of malignant tumours. (edition 6), Wiley-Liss, New York, 2002.
23. Bergkvist A, Ljungqvist A and Moberger G: Classification of bladder tumours based on the cellular pattern. Acta Chir Scand 130: 371-378, 1965.
24. Jackson P, Kingsley EA and Russell PJ: Inverse correlation between KAI1 mRNA levels and invasive behaviour in bladder cancer cell lines. Cancer Lett 156: 9-17, 2000. (Pubitemid 30326762)
25. Brown JL, Russell PJ, Philips J, Wotherspoon J and Ragahavan D: Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity. Br J Cancer 61: 369-376, 1990. (Pubitemid 20106007)
26. White A, Lamb PW and Barrett JC: Frequent down-regulation of the KAI1 (CD82) metastasis suppressor protein in human cancer cell lines. Oncogene 16: 3143-3149, 1998. (Pubitemid 28318785)
27. Zhou B, Liu L, Reddivari M and Zhang XA: The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity. Cancer Res 64: 7455-7463, 2004. (Pubitemid 39372088)
28. Rowe A and Jackson P: Expression of KITENIN, a KAI1/CD82 binding protein and metastasis enhancer, in bladder cancer cell lines: relationship to KAI1/CD82 levels and invasive behaviour. Oncol Rep 16: 1262-1273, 2006.
29. Dong JT, Isaacs WB, Barrett JC and Isaacs JT. Genomic organisation of the human KAI1 metastasis suppressor gene. Genomics 41: 25-32, 1997. (Pubitemid 27152817)